Veliparib for the treatment of solid malignancies
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552221073990
Abstract: Objective Veliparib is a poly adenosine diphosphate ribose polymerase (PARP) −1 and −2 inhibitor with chemo-sensitizing and anticancer activities that has shown promising results in early-phase trials. The aim of this comprehensive review is to… read more here.
Keywords: oncology; solid malignancies; treatment solid; veliparib treatment ... See more keywords